索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]张英 刘秋梅 高宇 金凤表 刘晓腾 刘慧卿 侯瑞田.白细胞介素-18与冠状动脉粥样硬化性心脏病合并高血压的相关研究[J].国际心血管病杂志,2019,04:233-234.
点击复制

白细胞介素-18与冠状动脉粥样硬化性心脏病合并高血压的相关研究(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2019年04期
页码:
233-234
栏目:
综述
出版日期:
2019-09-27

文章信息/Info

Title:
-
作者:
张英 刘秋梅 高宇 金凤表 刘晓腾 刘慧卿 侯瑞田
067000 承德医学院附属医院心脏电生理科
Author(s):
-
关键词:
白细胞介素-18;  冠状动脉粥样硬化性心脏病;  高血压;  治疗
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2019.04.012
文献标识码:
-
摘要:
白细胞介素-18(IL-18)是高血压和冠状动脉粥样硬化性心脏病(冠心病)的共同促炎因子,研究表明IL-18增加了两病的风险。该文主要介绍IL-18与冠心病合并高血压之间的关系及其干预治疗现状。
Abstract:
-

参考文献/References

[ 1 ] Bazgir A, Farazmandfar T, Salehi A, et al. Association of, interleukin-18, gene promoter polymorphisms with coronary artery disease in northern Iranian population[J]. Meta Gene, 2018, 16(1):1-4.
[ 2 ] Vm M, Al S, Aa A, et al. Circulating interleukin-18: Association with IL-8, IL-10 and VEGF serum levels in patients with and without heart rhythm disorders[J]. Int J Cardiol, 2016, 215:105-109.
[ 3 ] Novick D, Kim S, Kaplanski G, et al. Interleukin-18, more than a Th1 cytokine[J]. Semin Immunol, 2013, 25(6):439-448.
[ 4 ] Allam O, Samarani S, Jenabian MA, et al. Differential synthesis and release of IL-18 and IL-18 binding protein from human platelets and their implications for HIV infection[J]. Cytokine, 2017, 90:144-154.
[ 5 ] Sokolic J, Tokmadzic VS, Knezevic D, et al. Endothelial dysfunction mediated by interleukin-18 in patients with ischemic heart disease undergoing coronary artery bypass grafting surgery[J]. Med Hypotheses, 2017, 104(1):20-24.
[ 6 ] Hernesniemi JA, Anttila K, Nieminen T, et al. IL-18 gene polymorphism, cardiovascular mortality and coronary artery disease[J]. Eur J Clin Invest, 2010, 40(11):994-1001.
[ 7 ] Li Q, Kuang Y, Qiu J, et al. The correlation between plasma tissue factor and interleukin 18 and their signifi cance in patients with acute coronary syndrome[J]. Cardiovasc Toxicol, 2015, 15(3):276-282.
[ 8 ] ÖZzbïçer S, Uluçam ZM, et al. Association between interleukin-18 level and left ventricular mass index in hypertensive patients[J]. Korean Circ J, 2017, 7(2):238-244.
[ 9 ] inflammatory markers or mediators of hypertension?[J]. Br J Pharmacol, 2014, 171(24):5589-5602.
[10] Tanvir TC, Okamura T, Arfan AR, et al. Impact of hypertension on the lifetime risk of coronary heart disease[J]. Hypertension Res, 2016, 39(7):548-551.
[11] 夏芳芳, 栾天竹, 梁兆光, 等. HMGB1与冠心病关系的研究进展[J]. 现代生物医学进展, 2015, 15(29):5765-5767.
[12] Dzau VJ. Theodore cooper lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis[J]. Hypertension, 2001, 37(4):1047-1052.
[13] Sahar S, Dwarakanath RS, Reddy MA, et al. Angiotensin Ⅱ enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis[J]. Circ Res, 2005, 96(10):1064-1071.
[14] Santisteban MM, Zubcevic J, Baekey DM, et al. Dys-functional brain-bone marrow communication: a paradigmshift in the pathophysiology of hypertension[J]. Curr Hypertens Rep, 2013, 15(4):377-389.
[15] Murray DR, Mummidi S, Valente AJ, et al. β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo[J]. J Mol Cell Cardiol, 2012, 52(1):206-218.

备注/Memo

备注/Memo:
基金项目:承德市技术研究与发展计划项目(201801A026)
作者单位:067000 承德医学院附属医院心脏电生理科
通信作者:侯瑞田,Email:525915174@qq.com
更新日期/Last Update: 2019-09-27